Form 8-K - Current report:
SEC Accession No. 0001193125-25-327575
Filing Date
2025-12-22
Accepted
2025-12-22 07:32:21
Documents
10
Period of Report
2025-12-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sln-20251218.htm   iXBRL 8-K 56951
  Complete submission text file 0001193125-25-327575.txt   207000

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20251218.xsd EX-101.SCH 54707
12 EXTRACTED XBRL INSTANCE DOCUMENT sln-20251218_htm.xml XML 6329
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 251589496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)